2.The RBE of Fractionated Fast Neutron on Walker 256 Carcinosarcoma with KCCH-Cyclotron.
Seong Yul YOO ; Kyoung Hwan KOH ; Chul Koo CHO ; Charn Il PARK ; Wee Saing KANG
Journal of the Korean Society for Therapeutic Radiology 1987;5(2):75-82
For evaluation of biological effect of p+(50.5 MeV) Be neutron beam produced by Korea Cancer Center Hospital(KCCH) cyclotron the RBE had been measured in experimental tumor Walker 256 carcinosarcoma as well as normal tissue, mouse intestine and bone marrow, in single and fractionated irradiation. As pilot study, the RBE had been measured for the mouse jejunal crypt cells in single whole body irradiation of which the result was 2.8. The obtained RBE values of TCD 50 of Walker 256 tumor, bone marrow and intestine in single irraiation were 1.9, 1.9 and 1.5 respectively. In fractionated irradiation, the RBE value of tumor Walker 256 was decreased as increasing of fraction number and increased as increaing of fraction size.
Animals
;
Bone Marrow
;
Carcinosarcoma*
;
Cyclotrons
;
Fast Neutrons*
;
Intestines
;
Korea
;
Mice
;
Neutrons
;
Pilot Projects
;
Whole-Body Irradiation
3.Development of a monoclonal antibody against deoxynivalenol for magnetic nanoparticle-based extraction and an enzyme-linked immunosorbent assay.
Hyuk Mi LEE ; Sung Ok SONG ; Sang Ho CHA ; Sung Bok WEE ; Karyn BISCHOFF ; Sung Won PARK ; Seong Wan SON ; Hwan Goo KANG ; Myung Haing CHO
Journal of Veterinary Science 2013;14(2):143-150
Monoclonal antibody (mAb, NVRQS-DON) against deoxynivalenol (DON) was prepared. DON-Ag coated enzyme linked immunosorbent assay (ELISA) and DON-Ab coated ELISA were prepared by coating the DON-BSA and DON mAb. Quantitative DON calculation ranged from 50 to 4,000 ng/mL for DON-Ab coated ELISA and from 25 to 500 ng/mL for DON-Ag coated ELISA. 50% of inhibitory concentration values of DON, HT-2, 15-acetyl-DON, and nivalenol were 23.44, 22,545, 5,518 and 5,976 ng/mL based on the DON-Ab coated ELISA. Cross-reactivity levels of the mAb to HT-2, 15-acetyl-DON, and nivalenol were 0.1, 0.42, and 0.40%. The intra- and interassay precision coefficient variation (CV) were both <10%. In the mAb-coated ELISA, mean DON recovery rates in animal feed (0 to 1,000 microg/kg) ranged from 68.34 to 95.49% (CV; 4.10 to 13.38%). DON in a buffer solution (250, 500 and 1,000 ng/mL) was isolated using 300 microg of NVRQS-DON and 3 mg of magnetic nanoparticles (MNPs). The mean recovery rates of DON using this mAb-MNP system were 75.2, 96.9, and 88.1% in a buffer solution spiked with DON (250, 500, and 1,000 ng/mL). Conclusively we developed competitive ELISAs for detecting DON in animal feed and created a new tool for DON extraction using mAb-coupled MNPs.
Animal Feed/analysis
;
Animals
;
Antibodies, Fungal/analysis
;
Antibodies, Monoclonal/analysis
;
Chemistry Techniques, Analytical/*methods
;
Enzyme-Linked Immunosorbent Assay/*methods/veterinary
;
Female
;
Food Contamination/*analysis
;
Fusarium/immunology
;
Imidazoles/chemistry
;
Magnetics/methods
;
Mice
;
Mice, Inbred BALB C
;
Mycotoxins/*analysis/chemistry
;
Nanoparticles/chemistry
;
Ovalbumin/chemistry
;
Trichothecenes/*analysis/chemistry
4.Flow Cytometric Analysis of Lymphocyte Subpopulations of Cattle Infected with Bovine Leukemia Virus.
Soon Seek YOON ; You Chan BAE ; Yi Seok JOO ; Seong Hwan WEE ; Kyung Woo LEE ; Gook Hyun SUH ; Yong Ho PARK ; Hong Ryul HAN
Journal of Bacteriology and Virology 2005;35(2):165-173
We examined lymphocyte subpopulations of peripheral blood from BLV infected and noninfected Holstein-Friesian dairy cattle reared in Korea by flow cytometry using monoclonal antibodies specifically reactive with bovine leukocyte differentiation marker. Lymphocyte subpopulations expressing BoCD11b, B-B2, CD5, B, MHC II-DP, MHC II-DQ, and MHC II-DR antigens were significantly abundant in the BLV(+) group than the BLV(-) group (p<0.01). On double staining, subpopulation of B-1a(BoCD5+ BoCD11b+) lymphocytes was significantly increased in leukemic group. However, T-lymphocyte lineage expressing BoCD2, BoCD4, BoCD8, and WC1 antigens was significantly lower than in the BLV(+) group (p<0.01). However the absolute number of T-lymphocytes expressing BoCD2, BoCD4, BoCD8, and WC1 antigens in BLV(+) group remained with in the normal range. Furthermore mean ratio of BoCD4/BoCD8 in the BLV(+) groups was higher than that in the BLV(-) group. Taken together, cellular immune responses did not seem to significantly be decreased in the leukemic cattle.
Animals
;
Antibodies, Monoclonal
;
Cattle*
;
Enzootic Bovine Leukosis*
;
Flow Cytometry
;
Immunity, Cellular
;
Korea
;
Leukemia Virus, Bovine*
;
Leukocytes
;
Lymphocyte Subsets*
;
Lymphocytes*
;
Reference Values
;
T-Lymphocytes
5.Serum Globotriaosylceramide Assay as a Screening Test for Fabry Disease in Patients with ESRD on Maintenance Dialysis in Korea.
Jeong Yup KIM ; Young Youl HYUN ; Ji Eun LEE ; Hye Ran YOON ; Gu Hwan KIM ; Han Wook YOO ; Seong Tae CHO ; No Won CHUN ; Byoung Chunn JEOUNG ; Hwa Jung KIM ; Keong Wook KIM ; Seong Nam KIM ; Yung A KIM ; Hyun Ah LEE ; Jong Young LEE ; Yung Chun LEE ; Hun Kwan LIM ; Keong Sik OH ; Seong Hwan SON ; Beong Hee YU ; Kyeong So WEE ; Eun Jong LEE ; Young Ki LEE ; Jung Woo NOH ; Seung Jung KIM ; Kyu Bok CHOI ; Suk Hee YU ; Heui Jung PYO ; Young Joo KWON
The Korean Journal of Internal Medicine 2010;25(4):415-421
BACKGROUND/AIMS: Fabry disease is an X-linked recessive and progressive disease caused by alpha-galactosidase A (alpha-GaL A) deficiency. We sought to assess the prevalence of unrecognized Fabry disease in dialysis-dependent patients and the efficacy of serum globotriaosylceramide (GL3) screening. METHODS: A total of 480 patients of 1,230 patients among 17 clinics were enrolled. Serum GL3 levels were measured by tandem mass spectrometry. Additionally, we studied the association between increased GL3 levels and cardiovascular disease, cerebrovascular disease, or left ventricular hypertrophy. RESULTS: Twenty-nine patients had elevated serum GL3 levels. The alpha-GaL A activity was determined for the 26 patients with high GL3 levels. The mean alpha-GaL A activity was 64.6 nmol/hr/mg (reference range, 45 to 85), and no patient was identified with decreased alpha-GaL A activity. Among the group with high GL3 levels, 15 women had a alpha-GaL A genetics analysis. No point mutations were discovered among the women with high GL3 levels. No correlation was observed between serum GL3 levels and alpha-GaL A activity; the Pearson correlation coefficient was 0.01352 (p = 0.9478). No significant correlation was observed between increased GL3 levels and the frequency of cardiovascular disease or cerebrovascular disease. CONCLUSIONS: Fabry disease is very rare disease in patients with end-stage renal disease. Serum GL3 measurements as a screening method for Fabry disease showed a high false-positive rate. Thus, serum GL3 levels determined by tandem mass spectrometry may not be useful as a screening method for Fabry disease in patients with end stage renal disease.
Adult
;
Aged
;
Fabry Disease/blood/*diagnosis
;
Female
;
Humans
;
Kidney Failure, Chronic/blood/*therapy
;
Male
;
Middle Aged
;
*Renal Dialysis
;
Trihexosylceramides/*blood
;
alpha-Galactosidase/genetics/metabolism
6.Epidemiologic Studies of Keratoplasty in Korea.
Si Hwan CHOI ; Yang Won LEE ; Hyo Myung KIM ; Sun Mo YANG ; Jong Ug HONG ; Kyung Chul YOON ; Eui Sang CHUNG ; Hung Won TCHAH ; Kyung Hyun JIN ; Hee Tae CHO ; Chun Ki JOO ; Eung Gwon KIM ; Kyung Hwan SHYN ; Do Hyung LEE ; Tae Hun CHOI ; Jong Soo LEE ; Wan Soo KIM ; Jun HER ; Won Ryang WEE ; Mee Kum KIM ; Sang Bumm LEE ; Jae Chan KIM ; Hyung Joon KIM ; Hyung Keun LEE ; Jae Duck KIM ; Woo Chan PARK ; Seong Geun JEONG ; Tae Jung YOON
Journal of the Korean Ophthalmological Society 2006;47(4):538-547
PURPOSE: To report an epidemiologic study of keratoplasty in which we analyze basic data of corneal transplants and corneal donations in Korea. METHODS: From June 2004 through October 2004, questionnaires were distributed to 25 hospitals. The questionnaires were about the characteristics of patients registered in eye banks for keratoplasty from May 2001 to April 2003, and about the results of keratoplasties performed from May 2002 to April 2003. RESULTS: The leading corneal diseases in patients registered for keratoplasty were infectious keratitis (22.0%), trauma (21.0%), and pseudophakic and aphakic bullous keratopathy (13.8%), in that order. The leading indications in corneal recipients were: trauma (15.5%), pseudophakic and aphakic bullous keratopathy (13.7%), and infectious keratitis (10.7%), in that order. In 233 cases of keratoplasties, penetrating keratoplasty was performed in 229 cases (98.3%) and lamellar keratoplasty was performed in 4 cases (1.7%). The most common combined surgery was cataract extraction. Common causes of graft failure were rejection of donor cornea and infection. Imported donor corneas were used in sixty-one cases (26.2%) among the 233 total keratoplasties. CONCLUSIONS: We constructed an epidemiologic data base of patients registered for keratoplasty, corneal donation, and the results of keratoplasties throughout Korea.
Cataract Extraction
;
Cornea
;
Corneal Diseases
;
Corneal Transplantation*
;
Epidemiologic Studies*
;
Eye Banks
;
Humans
;
Keratitis
;
Keratoplasty, Penetrating
;
Korea*
;
Surveys and Questionnaires
;
Tissue Donors
;
Transplants
7.Epidemiologic Studies of Keratoplasty in Korea.
Si Hwan CHOI ; Yang Won LEE ; Hyo Myung KIM ; Sun Mo YANG ; Jong Ug HONG ; Kyung Chul YOON ; Eui Sang CHUNG ; Hung Won TCHAH ; Kyung Hyun JIN ; Hee Tae CHO ; Chun Ki JOO ; Eung Gwon KIM ; Kyung Hwan SHYN ; Do Hyung LEE ; Tae Hun CHOI ; Jong Soo LEE ; Wan Soo KIM ; Jun HER ; Won Ryang WEE ; Mee Kum KIM ; Sang Bumm LEE ; Jae Chan KIM ; Hyung Joon KIM ; Hyung Keun LEE ; Jae Duck KIM ; Woo Chan PARK ; Seong Geun JEONG ; Tae Jung YOON
Journal of the Korean Ophthalmological Society 2006;47(4):538-547
PURPOSE: To report an epidemiologic study of keratoplasty in which we analyze basic data of corneal transplants and corneal donations in Korea. METHODS: From June 2004 through October 2004, questionnaires were distributed to 25 hospitals. The questionnaires were about the characteristics of patients registered in eye banks for keratoplasty from May 2001 to April 2003, and about the results of keratoplasties performed from May 2002 to April 2003. RESULTS: The leading corneal diseases in patients registered for keratoplasty were infectious keratitis (22.0%), trauma (21.0%), and pseudophakic and aphakic bullous keratopathy (13.8%), in that order. The leading indications in corneal recipients were: trauma (15.5%), pseudophakic and aphakic bullous keratopathy (13.7%), and infectious keratitis (10.7%), in that order. In 233 cases of keratoplasties, penetrating keratoplasty was performed in 229 cases (98.3%) and lamellar keratoplasty was performed in 4 cases (1.7%). The most common combined surgery was cataract extraction. Common causes of graft failure were rejection of donor cornea and infection. Imported donor corneas were used in sixty-one cases (26.2%) among the 233 total keratoplasties. CONCLUSIONS: We constructed an epidemiologic data base of patients registered for keratoplasty, corneal donation, and the results of keratoplasties throughout Korea.
Cataract Extraction
;
Cornea
;
Corneal Diseases
;
Corneal Transplantation*
;
Epidemiologic Studies*
;
Eye Banks
;
Humans
;
Keratitis
;
Keratoplasty, Penetrating
;
Korea*
;
Surveys and Questionnaires
;
Tissue Donors
;
Transplants